  
- 积分
- 731
- 威望
- 731
- 包包
- 1397
|
本帖最后由 痞子的烟头 于 2010-7-24 12:47 编辑 3 _2 _' q" ?% Y3 Z1 V7 o
) V# @$ g- c" V' G9 h5 t1.Abstract
# U8 _8 u3 b' K' r& cCarcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) in the diagnosis of oat-cell and non-oat-cell bronchial carcinoma
4 d, p1 _& _! B- n3 J* V* E- n1 ]2 bAvailable online 6 January 2006. + b+ e7 ?4 I# [1 y0 z
! E* ^/ h$ v2 n: s) l. B, b
2.Formos Med Assoc. 1991 Jul;90(7):631-6.# a1 U* i6 e2 a; a, q
Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
& z0 |5 ]! g q$ ? w( r, B; NLee YC, Yang PC, Kuo SH, Luh KT.
6 P! ?4 c6 }; _2 D9 ]* e1 Z' \ P# _
3。Lung Cancer. 1995 Oct;13(2):155-68.- ?, }. ]9 N4 q: \5 ~* v8 E! C4 n, D
Monitoring lung cancer with tissue polypeptide antigen: an ancillary, profitable serum test to evaluate treatment response and posttreatment disease status! w0 Q; C9 Z/ B" W: ]8 @
& |' M6 S4 z" o% j
4.Immunobiology. 2004;209(7):535-44.
M6 K4 c5 v. i5 ?7 gTumor immunotherapy with alternative reading frame peptide antigens.( h" V5 C: e. U# w
Graddis TJ, Diegel ML, McMahan CJ, Tsavler L, Laus R, Vidovic D.
: y O8 b/ L. m0 [
1 J& f2 V* ?- }" |5 u+ N5.Cancer Res. 1990 May 15;50(10):2997-3001.1 S/ s1 R; D% ^* z6 o
Polypeptide core of a human pancreatic tumor mucin antigen.
e& t+ _( a& c6 U# w; SLan MS, Hollingsworth MA, Metzgar RS.
( B$ c( C7 @0 F* P& U7 {# F% ~, _$ Q5 r% Z; D
6、Ann N Y Acad Sci. 2006 Jul;1070:233-8.5 g( |# D, X& W5 d \! D
Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis.
/ ] }; p3 Q4 [Delgado M, Gonzalez-Rey E, Ganea D.$ l& {2 {9 B( w
$ Q$ _- K% U4 I. VDepartment of Biological Sciences, Rutgers University, Newark, NJ, USA.' v! ~1 d1 J- b* J7 [9 \
6 g6 x( F/ n# |$ V ^6 \
7.Carcinoembryonic antigen, tissue polypeptide antigen and neuron-specific enolase pleural levels used to classify small-cell and non-small-cell lung cancer patients by discriminant analysis : Paone G, De Angelis G, Greco S, Fiorucci F, Bisetti A, Amegho F. Laboratory of Clinical Pathology, S. Gallicano Institute, via S. Gallicano 25/4, 1-00153 Rome. J Cancer Res Clin Oncol 1996;122:499–503 |
|